Trials / Completed
CompletedNCT01176773
Safety and Effectiveness of Juvéderm® Ultra Lip Injectable Gel for Lip Enhancement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Allergan Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the safety and effectiveness of Juvéderm® Ultra Lip Injectable Gel for lip enhancement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hyaluronic acid gel | Dosage per Investigator's discretion to obtain lip treatment goal; 1 touch-up treatment is allowed 14 days after initial treatment. Maximum total volume per subject is 2.0 mL |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-05-01
- Completion
- 2012-01-01
- First posted
- 2010-08-06
- Last updated
- 2014-10-13
- Results posted
- 2012-07-12
Locations
4 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01176773. Inclusion in this directory is not an endorsement.